REVIEW: Preventing mother‐to‐child transmission of HIV: successes and challenges
- 3 August 2005
- journal article
- review article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 112 (9) , 1196-1203
- https://doi.org/10.1111/j.1471-0528.2005.00716.x
Abstract
Mother‐to‐child transmission of HIV continues to be a major cause of infant morbidity and mortality in resource‐poor settings. Intrapartum and postpartum nevirapine‐based regimens have been introduced in many settings. New research has shown that better efficacy can be achieved with the addition of single‐dose nevirapine to short course zidovudine regimens, and that selection of nevirapine‐resistant virus can be reduced with a short postpartum combination antiretroviral cover. Women who need antiretroviral therapy for their own health should receive it in pregnancy, and access for pregnant women needs to be expanded urgently. The reduction of transmission through breastfeeding remains a challenge.Keywords
This publication has 52 references indexed in Scilit:
- Decreasing incidence of pregnancy by decreasing CD4 cell count in HIV-infected women in Côte d'Ivoire: a 7-year cohort studyAIDS, 2005
- HIV seropositive in pregnant South African women who initially refuse routine antenatal HIV screeningBJOG: An International Journal of Obstetrics and Gynaecology, 2005
- Articles criticising nevirapine trial may endanger babies' livesBMJ, 2005
- Allegations Raise Fears of Backlash Against AIDS Prevention StrategyScience, 2004
- Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview studyBMJ, 2004
- Comparison of Nevirapine (NVP) Resistance in Ugandan Women 7 Days vs. 6–8 Weeks after Single-Dose NVP Prophylaxis: HIVNET 012AIDS Research and Human Retroviruses, 2004
- Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settingsAIDS, 2004
- Short postexposure prophylaxis in newborn babies to reduce mother-to-child transmission of HIV-1: NVAZ randomised clinical trialThe Lancet, 2003
- Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trialThe Lancet, 2002
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999